Skip to contentC
CV Sciences, Inc.
C
CVSICV Sciences, Inc. Q3 2015 · 10-Q
Revenue$4.15M$4.15M+123.2% vs Q3 2014 Net Income-$989.55K-$989.55KN/M vs Q3 2014 EPS Diluted-$0.03-$0.03N/M vs Q3 2014 Gross Profit$2,458,797+119.1% Operating Income
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
CV Sciences, Inc. · CIK 1510964 · Engraved from SEC EDGAR
Operating Cash Flowderived$902,070N/M Free Cash Flowderived$902,069N/M Margins · derivedGross margin59.2%−1.1 pt vs Q3 2014
Operating margin-21.7%+4.6 pt vs Q3 2014
Net margin-23.8%+2.1 pt vs Q3 2014
ended Sep 30, 2015 · filed Nov 16, 2015 · 47 d after period end